Drug Shortage Report for SAXENDA

Last updated on 2025-04-01 History
Report ID 253826
Drug Identification Number 02437899
Brand name SAXENDA
Common or Proper name Liraglutide injection
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) LIRAGLUTIDE
Strength(s) 6MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes EA
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2025-10-01
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2025-04-01
Company comments Due to Canadian supply constraints, we anticipate a shortage of Saxenda® in October 2025. We are working closely with our partners at Health Canada on solutions.
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-04-01 French Compare
v4 2025-04-01 English Compare
v3 2025-04-01 French Compare
v2 2025-04-01 French Compare
v1 2025-04-01 English Compare

Showing 1 to 5 of 5